Gastroenterologie
a hepatologie

The Mutaflor® – Escherichia coli (Nissle 1917), serotype O6: K5: H1 – the best researched probiotic available

Milan Lukáš ^{Orcid.org  1}

+ Affiliation
¹ IBD clinical and research centre ISCARE a.s., Prague, Czech Republic

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Nissle A. Über die Grundlagen einer neuen ursachlichen Bekampfung der pathologischen Darmflora. Dtsch Med  Wochenschr 1916; 42: 1181–1184.
2. Kruis W, Frič P, Pokrotniekes J et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53 (11): 1617–1623.
3. Matthes H, Krummenerl T, Giensch M et al. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement and Altern Med 2010; 10: 13. doi: 10.1186/ 1472-6882-10-13.
4. Cukrowska B, Lodlnová-Zadnikova R, Enders C et al. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probio­tic E. coli strain Nis­sle 1917. Scand J Im­munol 2002; 55 (2) : 204– 209.